NYSE and NASDAQ Stock Price Targets and Analyst Ratings

Stay on top of the latest NYSE- and NASDAQ-listed stock analyst recommendations with our up-to-date list of stock price targets and analyst ratings. This page tracks newly issued analyst ratings, price targets, upgrades, downgrades, and other broker actions to help you see how Wall Street analysts view U.S. companies. Use these ratings to compare sentiment, spot shifts in outlook, and make more informed investment decisions.

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
A Agilent Technologies	Reiterated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Polark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$135.03 -0.7%		Peer Perform
ABG Asbury Automotive Group	Reiterated by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Lick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$189.95 +1.8%	$242.00	Overweight
ABVX Abivax	Upgraded by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Nierengarten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.50 -44.1%	$110.00 ➝ $90.00	Underperform ➝ Neutral
ABVX Abivax	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julian Harrison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.50 -44.1%	$150.00	Buy
ABVX Abivax	Target Raised by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason N. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.50 -44.1%	$131.00 ➝ $187.00	Market Outperform
ABVX Abivax	Downgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Faisal Khurshid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.50 -44.1%	$160.00 ➝ $90.00	Buy ➝ Hold
ABVX Abivax	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$72.50 -44.1%		Outperform
ABVX Abivax	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Judah Frommer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.50 -44.1%	$145.00 ➝ $132.00	Overweight
ABVX Abivax	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Renza Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.50 -44.1%	$140.00 ➝ $135.00	Buy
ACN Accenture	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$186.27 -5.2%	$210.00 ➝ $199.00	Hold
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ACRE Ares Commercial Real Estate	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marissa Lobo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.03 +1.9%	$5.00 ➝ $5.50	Neutral
ACRS Aclaris Therapeutics	Initiated by	Lifesci Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.63 +6.7%	$13.00	Outperform
AESI Atlas Energy Solutions	Upgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Rollyson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.02 +5.3%	$25.00	Market Perform ➝ Outperform
AGYS Agilysys	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$89.74 -4.1%	$110.00	Overweight
AKTS Aktis Oncology	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.26 +4.0%	$33.00 ➝ $35.00	Buy
ALB Albemarle	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$172.12 +0.6%	$153.00 ➝ $192.00	Hold
ALGT Allegiant Travel	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Didora Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$87.67 -1.7%	$90.00 ➝ $100.00	Neutral
ALT Altimmune	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.90 -3.7%		Market Outperform
ARMK Aramark	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gary Bisbee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.06 -0.6%	$59.00 ➝ $62.00	Buy
ARXS Arxis	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Godyn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.84 -0.6%	$42.00 ➝ $50.00	Buy
ASST Strive	Initiated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Palmer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.12 -6.3%	$32.00	Buy
ASTH Astrana Health	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Larsen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.91 -2.3%	$50.00	Buy
BBY Best Buy	Target Raised by	Daiwa Securities Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$72.93 -2.7%	$68.00 ➝ $77.00	Neutral
BLCO Bausch + Lomb	Target Set by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$14.97 -2.7%	$19.00	Buy
BSX Boston Scientific	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marie Thibault Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$47.68 -0.6%	$65.00	Buy
BTSG BrightSpring Health Services	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Erin Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$59.34 -1.1%	$62.00 ➝ $71.00	Overweight
BWA BorgWarner	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Colin Langan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$74.18 +4.4%	$68.00 ➝ $83.00	Overweight
BXMT Blackstone Mortgage Trust	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marissa Lobo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.30 +2.0%	$20.00 ➝ $21.00	Neutral ➝ Buy
BXP BXP	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$61.12 +3.4%	$68.00	Outperform
CAG Conagra Brands	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan Adams Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.86 -1.9%	$16.00 ➝ $13.00	Neutral
CAT Caterpillar	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$910.03 +5.2%	$900.00	Neutral
CELC Celcuity	Target Set by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Berens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$91.42 -25.7%	$155.00
CHWY Chewy	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Doug Anmuth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.48 -3.6%	$40.00 ➝ $35.00	Overweight
CIEN Ciena	Target Raised by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dave Kang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$628.98 +10.4%	$283.00 ➝ $531.00	Neutral
CORT Corcept Therapeutics	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$71.20 +1.1%	$75.00 ➝ $95.00	Buy
CPB Campbell's	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Grom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.99 -0.4%	$20.00 ➝ $19.00	Sell
CRDO Credo Technology Group	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sean O'Loughlin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$229.00 +1.3%	$240.00 ➝ $260.00	Buy
CRDO Credo Technology Group	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Cardoso Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$229.00 +1.3%	$230.00 ➝ $250.00	Overweight
CRDO Credo Technology Group	Target Raised by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Suji Desilva Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$229.00 +1.3%	$200.00 ➝ $300.00	Buy
CRDO Credo Technology Group	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Blayne Curtis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$229.00 +1.3%	$225.00 ➝ $270.00	Buy
June 12: $100 Turns Into $100,000? (Ad) The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before major runs - says the window to get in early is closing fast. Brown is showing investors how to claim a stake in Elon Musk's company before it hits the public markets. Once the IPO happens, this pre-public opportunity disappears. Click here to see how to get ahead of the SpaceX IPO
CRDO Credo Technology Group	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vivek Arya Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$229.00 +1.3%	$210.00 ➝ $252.00	Buy
CRDO Credo Technology Group	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Genovese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$229.00 +1.3%	$175.00 ➝ $215.00	Neutral
CRDO Credo Technology Group	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Schneider Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$229.00 +1.3%	$250.00	Buy
CRDO Credo Technology Group	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$229.00 +1.3%	$260.00 ➝ $290.00	Outperform
CRDO Credo Technology Group	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Rolland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$229.00 +1.3%	$200.00 ➝ $235.00	Positive
CRWV CoreWeave	Initiated by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stefan Slowinski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$119.27 -4.4%	$192.00	Outperform
CZR Caesars Entertainment	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Trey Bowers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.22 +0.2%	$26.00 ➝ $31.00	Equal Weight
DELL Dell Technologies	Target Raised by	Daiwa Securities Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$433.72 -6.9%	$170.00 ➝ $465.00	Outperform
DG Dollar General	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scot Ciccarelli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$106.78 -2.9%	$114.00
DOCN DigitalOcean	Initiated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$172.67 -0.4%	$200.00	Overweight
DRTS Alpha Tau Medical	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.93 -7.6%	$15.00	Buy
DUK Duke Energy	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$120.88 +0.8%	$139.00	Buy
DVN Devon Energy	Target Lowered by	Capital One Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$46.24 -0.2%	$63.00 ➝ $61.00	Overweight
EBS Emergent Biosolutions	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.19 -3.6%		Buy
EBS Emergent Biosolutions	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.19 -3.6%		Buy
ED Consolidated Edison	Reiterated by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Crowdell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$103.75 +0.1%	$105.00	Outperform ➝ Neutral
EIKN Eikon Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.60 -11.0%		Overweight
ELVN Enliven Therapeutics	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Salim Syed Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.52 -5.3%	$45.00 ➝ $62.00	Outperform
ENHA Enhanced Group	Initiated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Susan Anderson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.84 -0.5%	$6.00	Buy
EW Edwards Lifesciences	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Jennings Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$87.59 -0.6%	$97.00 ➝ $104.00	Buy
EWTX Edgewise Therapeutics	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leonid Timashev Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.25 -7.5%	$50.00 ➝ $48.00	Outperform
EWTX Edgewise Therapeutics	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lander Egaña Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.25 -7.5%	$42.00 ➝ $45.00	Buy
EXP Eagle Materials	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adrian Huerta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$219.05 -0.9%	$225.00	Underweight ➝ Neutral
EXPO Exponent	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Chan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.39 -3.3%	$75.00	Neutral
FCX Freeport-McMoRan	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nick Cash Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$71.64 +6.9%	$68.00 ➝ $75.00	Buy
FDX FedEx	Target Lowered by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$328.76 -2.9%	$335.00 ➝ $269.76	Neutral
FDX FedEx	Target Lowered by	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$328.76 -2.9%	$375.00 ➝ $344.00	Neutral
FDX FedEx	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Hoexter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$328.76 -2.9%	$440.00 ➝ $376.00	Buy
FDX FedEx	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lucas Servera Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$328.76 -2.9%	$155.00
FLY Firefly Aerospace	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sheila Kahyaoglu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$43.37 -2.0%	$52.00	Buy
FOCL FocalTherics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.65 -2.7%	$10.00	Buy
FRSH Freshworks	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.16 -4.9%		Market Outperform
FULC Fulcrum Therapeutics	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.14 -51.1%	$4.00
FULC Fulcrum Therapeutics	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.14 -51.1%		Underperform ➝ Underweight
FULC Fulcrum Therapeutics	Downgraded by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Tenthoff Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.14 -51.1%	$3.00	Overweight ➝ Neutral
FULC Fulcrum Therapeutics	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Renza Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.14 -51.1%	$4.00	Buy ➝ Hold
FULC Fulcrum Therapeutics	Downgraded by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Condulis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.14 -51.1%	$3.00	Buy ➝ Hold
FULC Fulcrum Therapeutics	Downgraded by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Schwartz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.14 -51.1%	$4.00	Outperform ➝ Market Perform
FULC Fulcrum Therapeutics	Downgraded by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.14 -51.1%	$3.00	Buy ➝ Neutral
FVR FrontView REIT	Reiterated by	JonesTrading Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Erdner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.18 +1.4%	$19.00	Buy
GH Guardant Health	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Polark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$130.17 +0.8%	$150.00	Outperform
GH Guardant Health	Upgraded by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$130.17 +0.8%	$160.00	In-Line ➝ Outperform
GIS General Mills	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Yaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.07 -1.7%	$36.00	Neutral
GIS General Mills	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Grom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.07 -1.7%	$35.00 ➝ $30.00	Sell
GNRC Generac	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sean Milligan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$284.25 +5.6%		Buy
GNSS Genasys	Target Raised by	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Woo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.03 -3.8%	$5.50 ➝ $6.00	Buy
GOOG Alphabet	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$358.39 -3.8%	$435.00	Overweight
GOOGL Alphabet	Reiterated by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Rossington Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$361.85 -3.9%	$435.00 ➝ $420.00	Buy
GRAL GRAIL	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$59.90 -7.0%		Peer Perform
GWRE Guidewire Software	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Heckmann Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$162.51 -5.2%	$246.00	Buy
How to claim a stake in SpaceX before the June 12 IPO (Ad) SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in before the IPO. Jeff Brown, who identified Bitcoin, Tesla, and Nvidia before gains as high as 52,400%, 2,150%, and 32,000% respectively, is sharing the details on how to claim a stake in Elon Musk's company before it hits public markets. See exactly how to position yourself in SpaceX before June 12
GWRE Guidewire Software	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Allan Verkhovski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$162.51 -5.2%	$200.00	Buy
HPE Hewlett Packard Enterprise	Upgraded by	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ananda Baruah Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.05 +19.3%	$23.00 ➝ $75.00	Hold ➝ Buy
HPE Hewlett Packard Enterprise	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Vogt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.05 +19.3%	$25.00 ➝ $65.00	Neutral
HPE Hewlett Packard Enterprise	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Wamsi Mohan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.05 +19.3%	$38.00 ➝ $80.00	Buy
HPE Hewlett Packard Enterprise	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Rakers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.05 +19.3%	$26.00 ➝ $67.00	Equal Weight
HPE Hewlett Packard Enterprise	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Niknam Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.05 +19.3%	$31.00 ➝ $69.00	Buy
HPE Hewlett Packard Enterprise	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Asiya Merchant Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.05 +19.3%	$39.00 ➝ $70.00	Buy
HPE Hewlett Packard Enterprise	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Fish Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.05 +19.3%	$23.00 ➝ $63.00	Neutral
HPE Hewlett Packard Enterprise	Target Raised by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simon Leopold Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.05 +19.3%	$29.00 ➝ $74.00	Outperform
HPE Hewlett Packard Enterprise	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mehdi Hosseini Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.05 +19.3%	$21.00 ➝ $65.00	Neutral
HPE Hewlett Packard Enterprise	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Samik Chatterjee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.05 +19.3%	$37.00 ➝ $68.00	Overweight
HPE Hewlett Packard Enterprise	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tim Long Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.05 +19.3%	$28.00 ➝ $67.00	Overweight
HPE Hewlett Packard Enterprise	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Meta Marshall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.05 +19.3%	$33.00 ➝ $71.00	Equal Weight
HPE Hewlett Packard Enterprise	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark C. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.05 +19.3%	$35.00 ➝ $62.00	Market Perform
HPQ HP	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Ng Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.27 -7.1%	$16.00 ➝ $19.00	Sell
HRTX Heron Therapeutics	Downgraded by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$0.45 -45.6%		Buy ➝ Hold
HST Host Hotels & Resorts	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robin Farley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.65 +2.0%	$20.00 ➝ $23.00	Neutral
IAC IAC	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Kurnos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.86 -5.6%		Buy
IAUX i-80 Gold	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.63 +1.6%	$2.60
IBM International Business Machines	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$329.72 +2.9%		Buy
IBM International Business Machines	Target Set by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Ives Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$329.72 +2.9%	$350.00
IBRX ImmunityBio	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Y. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.23 -0.1%	$15.00	Buy
IDYA IDEAYA Biosciences	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Driscoll Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.87 -3.7%	$58.00	Outperform
IDYA IDEAYA Biosciences	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$27.87 -3.7%		Market Outperform
IEX IDEX	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan Blair Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$212.17 +2.2%	$242.00 ➝ $250.00	Outperform
INCY Incyte	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$92.24 -3.5%		Market Perform
INR Infinity Natural Resources	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Diamond Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.29 +0.2%	$25.00 ➝ $20.00	Buy
INTU Intuit	Downgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kash Rangan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$322.14 -8.9%	$519.00 ➝ $276.00	Neutral ➝ Sell
INTU Intuit	Target Lowered by	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$322.14 -8.9%	$700.00 ➝ $600.00	Buy
ISRG Intuitive Surgical	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$402.30 -2.4%	$440.00 ➝ $366.00	Sell
ISRG Intuitive Surgical	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Maeder Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$402.30 -2.4%	$580.00	Overweight
JBIO Jade Biosciences	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vamil Divan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.75 -4.5%	$47.00	Buy
JBIO Jade Biosciences	Target Set by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$17.75 -4.5%	$55.00
JBIO Jade Biosciences	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laura Chico Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.75 -4.5%	$34.00 ➝ $45.00	Outperform
JCI Johnson Controls International	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$142.06 +6.1%	$169.00 ➝ $178.00	Buy
JCI Johnson Controls International	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Deane Dray Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$142.06 +6.1%	$154.00	Sector Perform
JCI Johnson Controls International	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$142.06 +6.1%		Market Perform
JCI Johnson Controls International	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Amit Mehrotra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$142.06 +6.1%	$170.00 ➝ $180.00	Buy
KNX Knight-Swift Transportation	Upgraded by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bascome Majors Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$77.63 -0.4%	$90.00	Neutral ➝ Positive
KRMN Karman	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$54.63 +1.8%	$100.00	Outperform
LIN Linde	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Spector Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$495.91 -0.3%	$600.00	Buy
LINE Lineage	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ronald Kamdem Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.98 -2.4%	$39.00 ➝ $47.00	Equal Weight
LNG Cheniere Energy	Reiterated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$236.46 +3.8%	$300.00	Outperform
LTH Life Time Group	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Logan Reich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$32.18 +2.7%	$38.00 ➝ $43.00	Outperform
MAC Macerich	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Omotayo Okusanya Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.32 0.0%	$20.00 ➝ $27.00	Hold ➝ Buy
MANE Veradermics	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Serge Belanger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$98.48 -3.0%	$136.00	Buy
MCHP Microchip Technology	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Pradeep Ramani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$96.96 +5.9%		Buy
MDA MDA Space	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Greg Konrad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.30 -0.4%	$51.00	Buy
MDB MongoDB	Target Raised by	Tigress Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ivan Feinseth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$398.46 -1.3%	$430.00 ➝ $515.00	Buy
MDB MongoDB	Reiterated by	Tigress Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$398.46 -1.3%		Buy
I paid $5,000 to hear Elon say this (Ad) One investor paid $5,000 to be in a private room with Elon Musk in Los Angeles - and what he heard confirmed a conviction 15 years in the making. Musk is launching a project 27 years in the making that could be his biggest move yet. One analyst believes there is a single stock positioned to benefit most - and he is giving away the name for free. Get the free stock pick tied to Elon's most ambitious project
MELI MercadoLibre	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marvin Fong Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,672.83 -3.4%	$2,150.00	Buy
META Meta Platforms	Downgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$597.63 -0.5%		Buy ➝ Sell
META Meta Platforms	Upgraded by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$597.63 -0.5%		Positive
META Meta Platforms	Initiated by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$597.63 -0.5%		Outperform
META Meta Platforms	Upgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$597.63 -0.5%		Underperform ➝ Outperform
META Meta Platforms	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Ju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$597.63 -0.5%		Buy ➝ Neutral
META Meta Platforms	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Champion Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$597.63 -0.5%		Overweight
META Meta Platforms	Initiated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$597.63 -0.5%		Hold ➝ Buy
META Meta Platforms	Upgraded by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$597.63 -0.5%		Outperform ➝ Neutral
META Meta Platforms	Target Set by	Arete Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rocco Strauss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$597.63 -0.5%	$735.00	Neutral ➝ Buy
MGM MGM Resorts International	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$48.29 -4.7%	$48.00 ➝ $55.00	Buy
MIRM Mirum Pharmaceuticals	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yigal Nochomovitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$92.17 -4.3%	$145.00	Market Outperform ➝ Buy
MKC McCormick & Company, Incorporated	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Grom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.28 -0.6%	$53.00 ➝ $51.00	Neutral
MLM Martin Marietta Materials	Target Set by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$578.65 +1.3%	$556.00	Hold
MNPR Monopar Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$61.26 -4.9%		Buy
MNPR Monopar Therapeutics	Target Set by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$61.26 -4.9%	$105.00
MOBI Mobia Medical	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.78 +2.1%		Outperform
MOBI Mobia Medical	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Roman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.78 +2.1%	$31.00	Buy
MOBI Mobia Medical	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.78 +2.1%	$19.00	Buy
MOBI Mobia Medical	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Travis Steed Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.78 +2.1%	$16.00	Buy
MOBI Mobia Medical	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robbie Marcus Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.78 +2.1%	$15.00	Overweight
MRVL Marvell Technology	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tore Svanberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$290.79 +32.5%	$321.00
MSGS Madison Square Garden	Target Set by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curry Baker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$382.24 +1.2%	$470.00
MSM MSC Industrial Direct	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Newman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$115.04 +2.8%	$117.00 ➝ $120.00	Overweight
MSTR Strategy	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Palmer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$136.08 -9.1%		Buy
MSTR Strategy	Reiterated by	Monness Crespi & Hardt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$136.08 -9.1%		Neutral
MTD Mettler-Toledo International	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Polark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,170.40 -1.1%		Peer Perform
MTRN Materion	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Samuel McKinney Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$229.88 +3.1%	$223.00 ➝ $237.00	Overweight
NAVN Navan	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jared Levine Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.87 +0.4%	$19.00 ➝ $28.00	Buy
NBIS Nebius Group	Initiated by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stefan Slowinski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$260.58 -1.5%	$255.00	Neutral
NBIX Neurocrine Biosciences	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Corinne Johnson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$154.84 -3.8%	$213.00	Buy
NOAH Noah	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Zhang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.62 -0.3%	$12.00 ➝ $11.50	Neutral
NTAP NetApp	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$175.64 -2.3%	$200.00	Buy
NTRA Natera	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Polark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$213.05 -2.6%	$260.00	Outperform
NU NU	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mario Pierry Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.89 -8.4%	$16.00 ➝ $10.00	Neutral ➝ Underperform
NUTX Nutex Health	Initiated by	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Haynor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$125.03 -2.3%	$235.00	Buy
NUVL Nuvalent	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$91.35 -1.8%		Overweight
NVDA NVIDIA	Reiterated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$222.82 -0.7%		Outperform
NVDA NVIDIA	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	N. Quinn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$222.82 -0.7%	$270.00	Buy
ODD ODDITY Tech	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.84 -29.6%	$10.25	Hold
ODD ODDITY Tech	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.84 -29.6%		Hold
ODFL Old Dominion Freight Line	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bascome Majors Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$229.08 +0.2%	$205.00 ➝ $224.00	Neutral
ODTX Odyssey Therapeutics	Initiated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Nierengarten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.93 -0.2%	$30.00	Outperform
ODTX Odyssey Therapeutics	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Cheng Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.93 -0.2%	$26.00	Overweight
ODTX Odyssey Therapeutics	Initiated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Jones Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.93 -0.2%	$40.00	Outperform
ODTX Odyssey Therapeutics	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Van Buren Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.93 -0.2%		Buy
ODTX Odyssey Therapeutics	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Schmidt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.93 -0.2%		Overweight
OKTA Okta	Downgraded by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregg Moskowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$135.32 -3.2%	$110.00 ➝ $125.00	Outperform ➝ Neutral
ONC BeOne Medicines	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leonid Timashev Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$274.69 -1.8%	$425.00 ➝ $436.00	Outperform
OPTU Optimum Communications	Upgraded by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.18 +1.3%		Underperform ➝ Neutral
President Trump just sparked a stock market MELT UP (Ad) The real reason Musk, Huang, Cook, and Fink just flew to Beijing Last week, the CEOs of Nvidia, Apple, SpaceX, BlackRock, Goldman Sachs, Visa, Boeing, and more boarded Air Force One with President Trump to visit China. A U.S.-China trade deal would ignite a Melt Up in U.S. stocks, sending the market into a frenzy. Learn the exact moves one Florida millionaire says to make today – before this window closes.
ORCL Oracle	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Colville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$244.80 -1.4%	$215.00 ➝ $290.00	Sector Outperform
ORCL Oracle	Reiterated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Pat Colville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$244.80 -1.4%		Outperform
ORCL Oracle	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$244.80 -1.4%	$250.00 ➝ $285.00	Buy
ORKA Oruka Therapeutics	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$55.23 +0.4%	$180.00	Overweight
OXM Oxford Industries	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mauricio Serna Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.97 +2.9%	$33.00 ➝ $42.00	Neutral
PENG Penguin Solutions	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Cassidy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$70.65 +18.3%	$54.00 ➝ $65.00	Buy
PENG Penguin Solutions	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Chin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$70.65 +18.3%	$24.00 ➝ $66.00	Buy
PGNY Progyny	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Cherny Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.12 -4.1%	$29.00 ➝ $31.00	Buy
PRAX Praxis Precision Medicines	Target Lowered by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laura Chico Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$258.08 -23.0%	$166.00 ➝ $162.00	Underperform
PRAX Praxis Precision Medicines	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$258.08 -23.0%	$1,245.00 ➝ $1,201.00	Buy
PRAX Praxis Precision Medicines	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joel Beatty Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$258.08 -23.0%	$433.00 ➝ $400.00	Outperform
PRAX Praxis Precision Medicines	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jay Olson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$258.08 -23.0%	$750.00 ➝ $650.00	Outperform
PRAX Praxis Precision Medicines	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kambiz Yazdi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$258.08 -23.0%	$843.00 ➝ $810.00	Buy
PRAX Praxis Precision Medicines	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Hoang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$258.08 -23.0%	$420.00 ➝ $374.00	Buy
PRAX Praxis Precision Medicines	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$258.08 -23.0%		Buy
PRAX Praxis Precision Medicines	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Danielle Brill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$258.08 -23.0%	$715.00 ➝ $616.00	Buy
QBTS D-Wave Quantum	Target Raised by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Ellis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.97 +2.7%	$36.00 ➝ $40.00	Buy
QBTS D-Wave Quantum	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ruben Roy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.97 +2.7%	$35.00
QBTS D-Wave Quantum	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	N. Quinn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.97 +2.7%	$40.00	Buy
QBTS D-Wave Quantum	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John McPeake Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.97 +2.7%	$43.00	Buy
QBTS D-Wave Quantum	Target Raised by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Suji Desilva Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.97 +2.7%	$30.00 ➝ $40.00	Buy
RACE Ferrari	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$353.64 +1.3%		Outperform
RAPP Rapport Therapeutics	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$34.90 -6.0%		Market Outperform
RGEN Repligen	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Polark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$121.13 -1.6%	$145.00	Outperform
RIGL Rigel Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.02 +0.5%	$57.00	Buy
RPD Rapid7	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rudy Kessinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.43 -3.5%	$5.25 ➝ $6.50	Underperform
RPD Rapid7	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Meta Marshall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.43 -3.5%		Outperform ➝ Neutral
RVMD Revolution Medicines	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leonid Timashev Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$151.31 -7.6%	$165.00 ➝ $182.00	Outperform
RVTY Revvity	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Polark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.28 -0.2%		Peer Perform
RZLT Rezolute	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.00 +10.8%	$5.00	Buy
RZLT Rezolute	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.00 +10.8%	$6.00	Buy
RZLT Rezolute	Target Set by	Maxim Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason McCarthy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.00 +10.8%	$14.00
SAIA Saia	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bascome Majors Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$471.15 -2.3%	$425.00 ➝ $465.00	Neutral
SAIC Science Applications International	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Seth Seifman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$113.36 -1.5%	$110.00 ➝ $125.00	Neutral
SAIC Science Applications International	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Godyn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$113.36 -1.5%	$120.00 ➝ $132.00	Buy
SAIC Science Applications International	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tobey Sommer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$113.36 -1.5%	$95.00 ➝ $110.00	Hold
SAIL SailPoint	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Saket Kalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.84 +3.1%	$16.00 ➝ $22.00	Overweight
SARO StandardAero	Downgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sheila Kahyaoglu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.17 -8.0%	$34.00 ➝ $30.00	Buy ➝ Hold
SEZL Sezzle	Reiterated by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Hal Goetsch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$118.43 -3.4%	$117.00 ➝ $141.00	Buy
SHAK Shake Shack	Target Set by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Tamas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.95 -8.5%	$82.00	Outperform
SHAK Shake Shack	Target Set by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Curtis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.95 -8.5%	$70.00
SHAK Shake Shack	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$56.95 -8.5%	$66.00	Hold
SHW Sherwin-Williams	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Spector Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$292.65 -0.8%	$385.00 ➝ $330.00	Buy ➝ Neutral
SJM J. M. Smucker	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Grom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.34 -0.3%	$132.00 ➝ $121.00	Buy
SMG Scotts Miracle-Gro	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$56.47 -3.9%	$63.00	Neutral
SMPL Simply Good Foods	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Grom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.81 +1.3%	$13.00 ➝ $12.00	Neutral
SNDR Schneider National	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bascome Majors Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.44 +0.2%	$34.00 ➝ $36.00	Neutral
SOC Sable Offshore	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.59 +4.3%		Hold
SQM Sociedad Quimica y Minera	Upgraded by	CLSA Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$80.71 -3.2%		Outperform
SQM Sociedad Quimica y Minera	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$80.71 -3.2%	$100.00
SQM Sociedad Quimica y Minera	Downgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lucas Ferreira Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.71 -3.2%	$94.00 ➝ $100.00	Overweight ➝ Neutral
ST Sensata Technologies	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kosta Tasoulis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$53.21 +8.0%	$42.00 ➝ $48.00	Equal Weight
ST Sensata Technologies	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Snyder Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$53.21 +8.0%	$57.00	Buy
STM STMicroelectronics	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Didier Scemama Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.61 +15.3%	$73.00 ➝ $83.00	Neutral
STRL Sterling Infrastructure	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sangita Jain Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$875.52 +3.6%	$889.00 ➝ $922.00	Overweight
STVN Stevanato Group	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Polark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	€18.92 +0.3%	$21.00	Outperform
STWD Starwood Property Trust	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marissa Lobo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.09 +1.7%	$19.50 ➝ $20.00	Neutral ➝ Buy
STX Seagate Technology	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Asiya Merchant Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$926.61 +0.6%	$740.00 ➝ $1,150.00	Buy
TEM Tempus AI	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$49.62 -6.0%		Peer Perform
TFII TFI International	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bascome Majors Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.90 +1.7%	$134.00 ➝ $182.00	Positive
TMC TMC the metals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Heiko F. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.49 +2.0%	$11.75	Buy
TMHC Taylor Morrison Home	Downgraded by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Dahl Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$71.51 -0.1%	$69.00 ➝ $72.50	Outperform ➝ Sector Perform
TMO Thermo Fisher Scientific	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Polark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$480.62 -2.7%	$535.00	Outperform
TOL Toll Brothers	Target Set by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$139.40 +0.7%	$170.00
TPR Tapestry	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$138.64 -0.1%	$180.00	Outperform
TRIP TripAdvisor	Initiated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Piccolo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.94 -1.3%	$19.00	Neutral ➝ Outperform
TTWO Take-Two Interactive Software	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Callahan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$222.38 -2.0%	$280.00	Overweight
TVTX Travere Therapeutics	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.94 -4.7%	$57.00 ➝ $67.00	Buy
U Unity Software	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Callahan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.85 -4.1%	$35.00 ➝ $40.00	Overweight
UNCY Unicycive Therapeutics	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bruce D. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.23 -4.9%	$15.00 ➝ $18.00	Speculative Buy
URGN Urogen Pharma	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leland Gershell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.54 -1.8%		Outperform
V Visa	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$317.36 -1.7%	$450.00	Outperform
VC Visteon	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Colin Langan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.90 +4.9%	$125.00 ➝ $139.00	Overweight
VCTR Victory Capital	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$85.06 +0.5%	$90.00	Neutral
VCYT Veracyte	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$47.80 -0.8%	$55.00	Outperform
VERA Vera Therapeutics	Reiterated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$31.26 -7.9%		Outperform
VERA Vera Therapeutics	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$31.26 -7.9%	$90.00	Buy
VERA Vera Therapeutics	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$31.26 -7.9%	$60.00	Buy
VERA Vera Therapeutics	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$31.26 -7.9%		Buy
VMC Vulcan Materials	Target Set by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$282.06 +0.2%	$283.00	Hold
VRRM Verra Mobility	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Koning Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.16 -14.9%	$8.00 ➝ $6.00	Neutral
VVX V2X	Reiterated by	Noble Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$83.10 -0.7%		Outperform
WALD Waldencast	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Susan Anderson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.85 +1.1%	$2.00 ➝ $3.00	Buy
WAT Waters	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Polark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$371.90 -1.7%	$425.00	Outperform
WAT Waters	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derik De Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$371.90 -1.7%	$370.00 ➝ $400.00	Neutral
WDC Western Digital	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Asiya Merchant Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$563.10 +3.1%	$500.00 ➝ $685.00	Buy
WERN Werner Enterprises	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bascome Majors Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.99 +1.1%	$38.00 ➝ $47.00	Neutral
WS Worthington Steel	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Samuel McKinney Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$43.91 +2.9%	$38.00 ➝ $46.00	Overweight
WST West Pharmaceutical Services	Reiterated by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Etoch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$312.77 -1.1%	$360.00	Overweight
WT WisdomTree	Target Set by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Grondahl Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.96 -1.0%	$22.00
XFOR X4 Pharmaceuticals	Initiated by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.04 -1.7%	$12.00	Outperform
XPO XPO	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bascome Majors Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$216.67 -2.1%	$210.00 ➝ $212.00	Neutral
ZM Zoom Communications	Target Raised by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Bersey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$111.88 +0.2%	$107.00 ➝ $133.00	Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 12:02 AM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NYSE and NASDAQ Stock Price Targets and Analyst Ratings

Frequently Asked Questions